Long-term debt consists of the following:


	June 30, 2026			September 30, 2025
Series B term loan	$	736.0		$	733.9
Receivables financing agreement		153.7			61.6
Financing costs, net		(7.0	)		(5.3	)
Total debt, net	$	882.7		$	790.2
Less: Current portion of long-term debt		7.4			—
Long-term debt, net	$	875.3		$	790.2

On December 18, 2013, the Company and a group of financial institutions entered into a credit agreement (the “Credit Agreement”). The Credit Agreement consisted of seven-year $1,460.0 term loans and a five-year $210.0 revolving credit facility. All amounts outstanding under the Credit Agreement are collateralized by substantially all of the assets of the Company. The Credit Agreement, as amended, provides for: (i) a $1,200.0 seven-year term loan (the “Series B Term Loan”) and (ii) a $300.0 five-year revolving credit facility (the “Revolving Credit Facility”). There were no debt repayments for the Series B Term Loan for the three and nine months ended June 30, 2026 and 2025, respectively.

On August 28, 2023, the Company voluntarily repaid $450.0 of the amount outstanding under the Credit Agreement.

On January 29, 2025, the Company entered into Amendment No. 9 to the Credit Agreement (the "Ninth Credit Agreement Amendment"). Under the Ninth Credit Agreement Amendment, the existing Series B Term Loan were amended to bear interest at a rate per annum based on a secured overnight funding rate ("Term SOFR"), plus a margin of 2.00% or a base rate ("ABR") plus a margin of 1.00%, subject to SOFR and ABR floors of 0.50% and 1.50%, respectively.

On June 17, 2026, the Company entered into Amendment No. 11 to the Credit Agreement (the "Eleventh Credit Agreement Amendment"). Under the Eleventh Credit Agreement Amendment, the existing Series B Term Loans were amended to extend the maturity date through June 17, 2033. As a result of the repayment of the amounts outstanding under the Company's Amended Credit Agreement, the Company recorded a loss on debt extinguishment of $9.7 due to accelerated amortization of deferred financing fees and original issue discount included in the Other (expense) income line of the Consolidated Statements of Operations. An original issue discount of $2.0 was incurred when the company entered into the Eleventh Credit Agreement Amendment and is being amortized using the effective interest method over the life of the debt, resulting in an effective yield of 5.66%. The Eleventh Credit Agreement Amendment has required amortization debt repayments that are due in quarterly installments of 0.25% of the original principal balance of the Series B Term Loans of $738.0.

On May 4, 2026, the Company entered into Amendment No. 10 to the Credit Agreement (the "Tenth Credit Agreement Amendment"). The Tenth Credit Agreement Amendment amended certain terms of the Revolving Credit Facility. The Revolving Credit Facility matures on April 22, 2031 and bears interest at a rate per annum of Term SOFR plus a margin ranging from 1.75% to 2.25% or ABR plus a margin ranging from 0.75% to 1.25% subject to SOFR and ABR floors of 0.0% and 1.0%, respectively, with the margin on the Revolving Credit Facility determined based on the Company's first lien net leverage ratio. As a result of the repayment of the amounts outstanding under the Amended Credit Agreement, the Company recorded a loss on debit extinguishment of $0.1 due to the acceleration of deferred financing fees included in the Other (expense) income line on the Consolidated Statements of Operations. There were no borrowings or repayments under the facility during the three and nine months ended June 30, 2026 and 2025. The Company had no letters of credit issued and outstanding as of June 30, 2026 and September 30, 2025.

On April 28, 2017, the Company, through a wholly-owned subsidiary, entered into a receivables financing agreement (the “Receivables Financing Agreement”).

On June 27, 2024, the Company, through a wholly-owned subsidiary, entered into the Fifth Amendment to the Receivables Financing Agreement (the “Fifth Amendment”). The Fifth Amendment increased the borrowing capacity to $325.0, and (iii) established a swingline facility of up to $50.0.

On June 12, 2026, the Company, through a wholly-owned subsidiary, entered into the Sixth Amendment to the Receivables Financing Agreement (the "Sixth Amendment"). Under the terms of the Sixth Amendment, the Receivables Financing Agreement was amended to extend the term through June 12, 2029.

All amounts outstanding under the Receivables Financing Agreement are collateralized by substantially all of the accounts receivable and unbilled revenue of the Company. During the nine months ended June 30, 2026 the Company borrowed $105.1 against the capacity and voluntarily repaid $13.0. During the nine months ended June 30, 2025 the Company borrowed $14.5 against the capacity and voluntarily repaid $27.9. The Company had $89.9 of letters of credit issued and outstanding as of June 30, 2026 and $82.3 of letters of credit issued and outstanding as of September 30, 2025.

The following are the scheduled maturities of long-term debt for the remainder of fiscal 2026 and the following four fiscal years and thereafter, which do not include any estimated excess cash flow payments:


2026	$	1.8
2027		7.4
2028		7.4
2029		161.1
2030		7.4
2031 and thereafter		706.6
Total long-term debt		891.7
Less: Current maturities		7.4
Less: Original issue discount		2.0
Less: Financing costs		7.0
Total long-term debt, net	$	875.3

The Company has estimated the fair value of its long-term debt to be approximately $886.2 and $796.8 as of June 30, 2026 and September 30, 2025, respectively. Fair value is based on market bid prices around period-end (Level 2 inputs).